| Ytd | -57.30% | |
| 1y | -89.67% |
| Open | 1.49 | Prev Close | 1.50 | Low | 1.47 | High | 1.58 | Mkt Cap | 6.24M |
| Vol | 10.47K | Avg Vol | 3.98M | EPS | -22.74 | P/E | N/A | Forward P/E | -0.22 |
| Beta | 0.47 | Short Ratio | 0.31 | Inst. Own | 7.06% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | 04-23 | Earning | 08-15 | 50-d Avg | 2.45 | 200-d Avg | 4.15 | 1yr Est | 8.32 |
ENVB News
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”),
Enveric Biosciences (NASDAQ: ENVB) (âEnvericâ or the âCompanyâ), a biotechnology company adv
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”),
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”),
Studies are designed to evaluate the potential for the compound to interact with DNA and cause genet
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”),
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”),
Enveric Biosciences (NASDAQ: ENVB) (âEnvericâ or the âCompanyâ), a biotechnology company adv
Enveric Biosciences (NASDAQ:ENVB) reported quarterly losses of $(1.08) per share. This is a 92.62 pe
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”),
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”),
Enveric highlights EB-003 PTSD data as Trump-backed psychedelic research signals rising demand for n
Enveric Biosciences today highlighted preclinical data for its lead candidate, EB-003, a dual 5-HT2A
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”),
Appointment strengthens Board with seasoned public company biotech executive following recent Nasdaq
Enveric Biosciences, Inc (NASDAQ:ENVB) stock is trading higher on Friday after the U.S. Food and Dru
The FDA issues priority vouchers and clears early trials for ibogaine derivatives for using psychede
https://www.hhs.gov/press-room/fda-accelerates-action-treatments-serious-mental-illness-following-ex
https://ppubs.uspto.gov/api/pdf/downloadPdf/12605361?requestToken=eyJzdWIiOiJiMmQyZjdhNi0yZmM0LTQ4YT
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”),
Enveric surged more than 92% in premarket trading as investors rushed into psychedelic‑focused biote
Enveric BioSciences Inc. shares are soaring on Monday after President Trump order to accelerate appr
US stocks down at midday, Dow down 0.2%, NASDAQ down 0.52%. Energy up 1.1%, consumer discretionary d
US stocks mixed, energy shares climb. Cleveland-Cliffs falls 6% after reporting Q1 results. Enveric
Psychedelic drug maker shares jumped in Monday pre-market after an order from President Donald Trump
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences, Inc. (NASDAQ: ENVB) (“Enveric” or the “Compa
Blaize Holdings rose 24.3% in pre-market trading on $50M contract with NeoTensr & MOU with Winma
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences, Inc. (NASDAQ: ENVB) (“Enveric” or the “Compa
https://www.cbsnews.com/news/psychedelic-drug-ibogaine-ptsd-trump-to-sign-executive-order/
Enveric Biosciences (NASDAQ:ENVB) ("Enveric" or the "Company"), a biotechnology comp
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”),
Enveric Biosciences (NASDAQ:ENVB) reported quarterly losses of $(0.50) per share. This is a 99.14 pe
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”),
https://www.marijuanamoment.net/bipartisan-senators-file-bill-to-support-psychedelics-research-and-t
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”),
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”),